These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 33823526)

  • 1. Clinicogenetic Profile, Treatment Modalities, and Mortality Predictors of Gaucher Disease: A 15-Year Retrospective Study.
    Barney AM; Danda S; Abraham A; Fouzia NA; Gowdra A; Abraham SSC; Sony M; Das S; Korula S; Mathai S; Simon A; Kumar S
    Public Health Genomics; 2021; 24(3-4):139-148. PubMed ID: 33823526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease.
    Donald A; Björkvall CK; Vellodi A; ; Cox TM; Hughes D; Jones SA; Wynn R; Machaczka M
    Orphanet J Rare Dis; 2022 Jun; 17(1):234. PubMed ID: 35717194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaucher disease and its treatment options.
    Bennett LL; Mohan D
    Ann Pharmacother; 2013 Sep; 47(9):1182-93. PubMed ID: 24259734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaucher Disease: Clinical, Biological and Therapeutic Aspects.
    Dandana A; Ben Khelifa S; Chahed H; Miled A; Ferchichi S
    Pathobiology; 2016; 83(1):13-23. PubMed ID: 26588331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry.
    El-Beshlawy A; Tylki-Szymanska A; Vellodi A; Belmatoug N; Grabowski GA; Kolodny EH; Batista JL; Cox GF; Mistry PK
    Mol Genet Metab; 2017; 120(1-2):47-56. PubMed ID: 28040394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.
    Daykin EC; Ryan E; Sidransky E
    Mol Genet Metab; 2021 Feb; 132(2):49-58. PubMed ID: 33483255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.
    van Dussen L; Hendriks EJ; Groener JE; Boot RG; Hollak CE; Aerts JM
    J Inherit Metab Dis; 2014 Nov; 37(6):991-1001. PubMed ID: 24831585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaucher disease: clinical phenotypes and refining GBA mutational spectrum in Thai patients.
    Phetthong T; Tim-Aroon T; Khongkraparn A; Noojarern S; Kuptanon C; Wichajarn K; Sathienkijkanchai A; Suphapeetiporn K; Charoenkwan P; Tantiworawit A; Noentong N; Wattanasirichaigoon D
    Orphanet J Rare Dis; 2021 Dec; 16(1):519. PubMed ID: 34930372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment of pediatric Gaucher disease.
    Gupta P; Pastores G
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1183-1194. PubMed ID: 30444430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenic mechanism and therapies for Gaucher's disease].
    Liu LY; Du SC; Zhang J; Ma D
    Yi Chuan; 2015 Jun; 37(6):510-6. PubMed ID: 26351046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronopathic Gaucher disease presenting with microcytic hypochromic anemia.
    Kim EA; Lim YT; Hah JO; Sohn YB; Kim YK; Choi JH; Kim SY; Jang KM; Ahn J; Lee JM
    Int J Hematol; 2019 Mar; 109(3):361-365. PubMed ID: 30456712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and Management of Gaucher Disease in India - Consensus Guidelines of the Gaucher Disease Task Force of the Society for Indian Academy of Medical Genetics and the Indian Academy of Pediatrics.
    Puri RD; Kapoor S; Kishnani PS; Dalal A; Gupta N; Muranjan M; Phadke SR; Sachdeva A; Verma IC; Mistry PK;
    Indian Pediatr; 2018 Feb; 55(2):143-153. PubMed ID: 29503270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation causing type 1 Gaucher disease found in a Japanese patient with gastric cancer: A case report.
    Hosoba S; Kito K; Teramoto Y; Adachi K; Nakanishi R; Asai A; Iwasa M; Nishimura R; Moritani S; Kawahara M; Minamiguchi H; Nanba E; Kushima R; Andoh A
    Medicine (Baltimore); 2018 Jul; 97(27):e11361. PubMed ID: 29979419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive and long-term outcomes of enzyme replacement therapy followed by stem cell transplantation in children with Gaucher disease type 1 and 3.
    Anurathapan U; Tim-Aroon T; Zhang W; Sanpote W; Wongrungsri S; Khunin N; Chutipongtanate S; Chirdkiatgumchai V; Ngiwsara L; Jaovisidha S; Khongkraparn A; Pakakasama S; Svasti J; Setchell KDR; Wattanasirichaigoon D; Hongeng S
    Pediatr Blood Cancer; 2023 Mar; 70(3):e30149. PubMed ID: 36562549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report.
    Ceravolo F; Grisolia M; Sestito S; Falvo F; Moricca MT; Concolino D
    J Med Case Rep; 2017 Jan; 11(1):19. PubMed ID: 28103924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancements in Viral Gene Therapy for Gaucher Disease.
    Kulkarni A; Chen T; Sidransky E; Han TU
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.
    Baris HN; Cohen IJ; Mistry PK
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1(0 1):72-81. PubMed ID: 25345088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Treatment of Gaucher Disease With Matched Sibling Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review.
    Chavananon S; Sripornsawan P; Songthawee N; Chotsampancharoen T
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1153-e1155. PubMed ID: 33661172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaucher disease.
    Nagral A
    J Clin Exp Hepatol; 2014 Mar; 4(1):37-50. PubMed ID: 25755533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy.
    Sawicka-Gutaj N; Machaczka M; Kulińska-Niedziela I; Bernardczyk-Meller J; Gutaj P; Sowiński J; Ruchała M
    Ups J Med Sci; 2016 Aug; 121(3):192-5. PubMed ID: 27064303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.